Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2006
08/08/2006US7087381 Detection of target sequences by cleavage of non-target nucleic acids
08/08/2006US7087371 Producing semen via xenogenic tissue grafting of testis in animal models; preserving fertility in prepubescent males undergoing chemotherapeutic treatment
08/08/2006US7087261 Grain based feed that provide improved animal nutrition, and reduces the environmental impact of animal production
08/08/2006US7087231 In situ diagnosis of malaria
08/08/2006US7087230 Proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
08/08/2006US7087226 Lysin-deficient bacteriophages having reduced immunogenicity
08/08/2006US7087225 Nucleotide sequences coding polypeptide for use in treatment, diagnosis and prevention of bone disorders
08/08/2006CA2191624C Dna fragment, recombinant vector containing the same and method for expressing foreign genes using the same
08/08/2006CA2121481C Expression of polypeptides in e.coli under control of the e.coli mdh-gene promoter
08/08/2006CA2092680C Epstein-barr virus sequences and protein thereof
08/08/2006CA2071875C Recombinant human factor viii derivative
08/03/2006WO2006081546A2 Inhibitor nucleic acids
08/03/2006WO2006081207A2 Process for genetic engineering of cell lines
08/03/2006WO2006081074A2 Charge neutralization of polyion complexes
08/03/2006WO2006081008A2 Nucleic acids for apoptosis of cancer cells
08/03/2006WO2006080934A2 Electroporation apparatus and methods
08/03/2006WO2006080842A2 Oral vaccines for fish
08/03/2006WO2006080841A1 Means and methods for improving the development and maturation of eggs and/or sperm in fish using hormones produced by transplanted cells
08/03/2006WO2006080791A1 Method for enhancing environmental stress resistance of plant using environmental stress controlling gene
08/03/2006WO2006080682A1 Construct of swine vesicular disease virus like particle using genetic engineering and the method for manufacturing thereof
08/03/2006WO2006080598A1 Anther-specific genes derived from malus x domestica, promoters thereof and a method for preparing transformed plant using the same
08/03/2006WO2006080580A1 Apparatus for recovering specific substance and nucleic acid extracting apparatus using the same
08/03/2006WO2006080579A1 Method for preparing sample solution and sample solution preparing apparatus
08/03/2006WO2006080564A1 RNAi THERAPEUTIC AGENT HAVING NO ADVERSE SIDE EFFECT
08/03/2006WO2006080525A1 Thermally stable or thermally active dna polymerase and dna encoding the same
08/03/2006WO2006080501A1 METHOD OF QUANTITATIVELY ANALYSING MICROORGANISM TARGETING rRNA
08/03/2006WO2006080483A1 Novel dendritic cell membrane molecule and dna encoding the same
08/03/2006WO2006080409A1 5-substituted hydantoin racemase, dna encoding the same, recombinant dna, transformed cell, and process for production of optically active n-carbamylamino acid or optically active amino acid
08/03/2006WO2006080396A1 Quantitative measurement method for recombinant protein
08/03/2006WO2006080313A1 Method of enzymatically synthesizing 3’-phosphoadenosine-5’-phosphosulfate
08/03/2006WO2006080262A1 Age-2 aptamer
08/03/2006WO2006080248A1 Linear mammalian artificial chromosome and method of constructing the same
08/03/2006WO2006080193A1 Oncogene and diagnostic kit making use of the same
08/03/2006WO2006080192A1 Gene specific to cancer and diagnosis kit using the same
08/03/2006WO2006080142A1 Hla-binding peptides, dna fragments encoding the same and recombinant vectors
08/03/2006WO2006080136A1 Method of quickly extracting, purifying and cloning target gene by using closed circular double-stranded dna
08/03/2006WO2006080106A1 Diabetes model animal
08/03/2006WO2006079727A1 System for producing terpenoids in plants
08/03/2006WO2006079655A2 Plants having increased yield and a method for making the same
08/03/2006WO2006079565A2 Leishmania antigens suitable for a diagnostic kit of leishmania
08/03/2006WO2006079546A2 Production of antibodies in plants with plus -sense single -stranded viral rna vectors
08/03/2006WO2006079290A1 A recombinant sars-cov vaccine comprising attenuated vaccinia virus carriers
08/03/2006WO2006079244A1 Recombined adenovirus p53 preparation for treating tumor
08/03/2006WO2006065821A3 Improved dna immunization with recombinase/transposase
08/03/2006WO2006063247A3 Regulated expression of transgenes in the central nervous system of mammals
08/03/2006WO2006061425A3 Production of beta-lactam antibiotics by genetically modified non-naturally producing microorganisms
08/03/2006WO2006061418A3 Methods and agents useful in treating conditions characterized by mucus hyperproduction/hypersecretion
08/03/2006WO2006060332A3 Electroporation of mycobacterium and overexpression of antigens in mycobacteria
08/03/2006WO2006059323A3 Production of proteins
08/03/2006WO2006058620A3 Method for producing carboxy-terminal amidified peptides
08/03/2006WO2006056753A3 Humanised baculovirus
08/03/2006WO2006056176A3 Storage-induced promoter
08/03/2006WO2006054096A3 Soluble bifunctional proteins
08/03/2006WO2006053683A3 Gene silencing using sense dna and antisense rna hybrid constructs coupled to peptides facilitating the uptake into cells
08/03/2006WO2006052363A3 Co-expression of multiple protein chains or subunits
08/03/2006WO2006050734A3 Potent lna oligonucleotides for the inhibition of hif-1a expression
08/03/2006WO2006048768A3 Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal
08/03/2006WO2006048657A3 Fras related protein
08/03/2006WO2006047183A3 Recombinant dna nicking endonuclease and uses thereof
08/03/2006WO2006037960A3 T-cell receptors containing a non-native disulfide interchain bond linked to therapeutic agents
08/03/2006WO2006037038B1 Optimized vaccines to provide protection against ebola and other viruses
08/03/2006WO2006033409A8 Method of assaying anti-hcv agent with use of cyclophilin
08/03/2006WO2006026667A3 Recombinant mva viruses expressing glade a/g, clade b, and clade c modified hiv, gag and pol genes
08/03/2006WO2006017279A3 Methods and compositions related to identifying protein-protein interactions
08/03/2006WO2006015371A3 Humanized anti-cmet antagonists
08/03/2006WO2006013072A3 Method for isolation of transcription termination sequences
08/03/2006WO2006008266A3 Factor xi-binding proteins
08/03/2006WO2006005473A3 Rat trace amine associated receptors
08/03/2006WO2005121347A3 Recombinant constructs for use in reducing gene expression
08/03/2006WO2005117938A3 Methods of treating ocular conditions
08/03/2006WO2005113774A3 Methods for production of xylitol in microorganisms
08/03/2006WO2005111212A3 Biological bar code
08/03/2006WO2005103715A3 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
08/03/2006WO2005085288A3 Natural igm antibodies and inhibitors thereof
08/03/2006WO2005074641A3 Variant neuronal nicotinic alpha-7 receptor and methods of use
08/03/2006WO2005073250A3 Medical treatment using an rna1 targeting a human notch signalling pathway member
08/03/2006WO2005062890A3 Methods of treating cardiac disorders by suppressing the expression of the potassium inwardly-rectifying channel
08/03/2006WO2005056756A3 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis
08/03/2006WO2005049651A3 Cancer diagnosis and therapy
08/03/2006WO2005000200A3 Novel kinases
08/03/2006WO2004082399A3 Fish and the production thereof
08/03/2006WO2004060867A3 Secreted protein factor and cell membrane-bound splice variant
08/03/2006WO2004050838A3 Plant production of immunoglobulins with reduced fucosylation
08/03/2006WO2004039951A3 Il-1 receptor based antagonists and methods of making and using
08/03/2006WO2004001381A8 Novel raag10 cell surface target and a family of antibodies recognizing that target
08/03/2006WO2003072041A3 Assays to monitor amyloid precursor protein processing
08/03/2006WO2003014318A3 Methods for treating diabetes and other blood sugar disorders
08/03/2006WO2002102319A3 Polynucleotide encoding a novel human growth factor with homology to epidermal growth factor, bgs-8, expressed highly in immune tissue
08/03/2006US20060174382 Inbred corn line PH8WD
08/03/2006US20060174381 Soybean variety 91M70
08/03/2006US20060174380 Method to trigger RNA interference
08/03/2006US20060174379 Chitinase encoding DNA molecules from cotton expressed preferentially in secondary walled cells during secondary wall deposition and a corresponding promoter
08/03/2006US20060174378 High level production of arbutin in green plants and microbes
08/03/2006US20060174377 Novel glycosyltransferase gene
08/03/2006US20060174376 production of oils and/or triacylglycerides with an elevated content of long-chain polyunsaturated fatty acids using transgenic organisms; used in food industry, in animal nutrition, in cosmetics and in the pharmacological sector
08/03/2006US20060174375 introducing into progenitor cells of the plant a plant transformation vector comprising a heterologous constitutive promoter operatively linked to a nucleotide sequence that encodes a HIO32.2 polypeptide, growing the cell to produce transgenic plant with an altered oil content phenotype
08/03/2006US20060174374 Generation of plants with altered oil content
08/03/2006US20060174373 by expressing a polypeptide from yeast that when expressed will increase the total amount of oil (i.e. triacylglycerols TAG) that is produced in transgenic organisms
08/03/2006US20060174372 Plants transformed with polynucleotides encoding broad-spectrum delta-endotoxins
08/03/2006US20060174371 Modified DNA molecule with a nucleotide sequence which is 80% but less than 100% homologous to desired trait DNA molecules and which imparts the desired trait to plants transformed with the DNA construct